Interestingly, AMPD1 was also reported as a putative target of the diabetes drug metformin (Cheng et al., 2014), and AMPD1 deficient individuals have been reported to have decreased rates of diabetes (Safranow et al., 2009). Here, AMPD1 is linked to diabetes mellitus.